Tech Company Financing Transactions
QLIDA Diagnostics Funding Round
QLIDA Diagnostics closed a $250 thousand funding round on 2/8/2013. Backers included Ben Franklin Technology Partners.
Transaction Overview
Company Name
Announced On
2/8/2013
Transaction Type
Venture Equity
Amount
$250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
QLIDA develops next-generation biomarker diagnostic tests. The company's proprietary platform can be used for diagnosis of life-threatening diseases such as cancer and cardiovascular disease, through the use of a nanotechnology-based protein detection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Boyce-Jacino
Chief Scientific Officer
Michael Neidrauer
Browse more venture capital transactions:
Prev: 2/8/2013: AlchemyAPI venture capital transaction
Next: 2/8/2013: Kineta venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs